1. Home
  2. VERU vs HIT Comparison

VERU vs HIT Comparison

Compare VERU & HIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veru Inc.

VERU

Veru Inc.

SELL

Current Price

$2.09

Market Cap

41.9M

Sector

Health Care

ML Signal

SELL

Logo Health In Tech Inc.

HIT

Health In Tech Inc.

HOLD

Current Price

$0.36

Market Cap

42.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERU
HIT
Founded
1971
1964
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
41.9M
42.6M
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
VERU
HIT
Price
$2.09
$0.36
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
★ $25.67
$2.37
AVG Volume (30 Days)
★ 106.8K
60.1K
Earning Date
12-16-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 100.00
EPS
★ N/A
N/A
Revenue
$16,296,958.00
★ $33,327,511.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$70.91
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 70.99
52 Week Low
$2.04
$0.36
52 Week High
$7.33
$2.10

Technical Indicators

Market Signals
Indicator
VERU
HIT
Relative Strength Index (RSI) 40.86 23.60
Support Level $2.09 N/A
Resistance Level $2.68 $1.16
Average True Range (ATR) 0.11 0.09
MACD 0.00 -0.01
Stochastic Oscillator 26.67 3.21

Price Performance

Historical Comparison
VERU
HIT

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

About HIT Health In Tech Inc.

Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.

Share on Social Networks: